The US White House issued a statement on August 31, local time, saying that US President Trump announced new agreements with nine pharmaceutical companies to lower the price of prescription drugs in the US and keep them in line with MFN prices. As a result, the total number of pharmaceutical companies that have signed MFN agreements reached 26, covering 89% of the US brand drug market. The nine manufacturers are Alcon, Astellas Pharma, BeOne Medicines, BridgeBio, Jetbeylin, Kyowa Kirin, Taiyo Pharmaceuticals, Teva Pharmaceuticals, and Ushibai. The statement said that nine pharmaceutical companies promised to invest at least 19.6 billion US dollars in the US manufacturing industry in the near future.
Zhitongcaijing · 1d ago
Share
Listen to the news
The US White House issued a statement on August 31, local time, saying that US President Trump announced new agreements with nine pharmaceutical companies to lower the price of prescription drugs in the US and keep them in line with MFN prices. As a result, the total number of pharmaceutical companies that have signed MFN agreements reached 26, covering 89% of the US brand drug market. The nine manufacturers are Alcon, Astellas Pharma, BeOne Medicines, BridgeBio, Jetbeylin, Kyowa Kirin, Taiyo Pharmaceuticals, Teva Pharmaceuticals, and Ushibai. The statement said that nine pharmaceutical companies promised to invest at least 19.6 billion US dollars in the US manufacturing industry in the near future.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending